WHO Warns Poor Nations Could Be Pushed to 'End of the Queue' for Pfizer Covid Pill

"Pfizer must expand the license with the Medicines Patent Pool to include all developing countries."

Pfizer's oral antiviral drug is"the best therapeutic choice for high-risk patients to date," the United Nations health agency said in a. However, it added,"WHO is extremely concerned that—as occurred with Covid-19 vaccines—low- and middle-income countries will again be pushed to the end of the queue when it comes to accessing this treatment."

"One obstacle for low- and middle-income countries is that the medicine can only be administered while the disease is at its early stages; prompt and accurate testing is therefore essential for a successful outcome with this therapy," said WHO."Data collected by show that the average daily testing rate in low-income countries is as low as one-eightieth the rate in high-income countries."

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WHO backs Pfizer's oral COVID therapy for high-risk patientsThe World Health Organization (WHO) on Thursday endorsed the use of Pfizer Inc's oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by the U.N. agency showed the therapy dramatically cut the risk of hospitalisation. I don’t know. Who?
Source: Reuters - 🏆 2. / 97 Read more »

Biden Admin to Promote Availability of COVID Antiviral PillPresident Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed
Source: NBCLA - 🏆 319. / 59 Read more »